These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28391887)

  • 1. Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.
    Turner RM; Yin P; Hanson A; FitzGerald R; Morris AP; Stables RH; Jorgensen AL; Pirmohamed M
    J Clin Lipidol; 2017; 11(1):204-214. PubMed ID: 28391887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes.
    Xie G; Sun Y; Myint PK; Patel A; Yang X; Li M; Li X; Wu T; Li S; Gao R; Wu Y
    Lipids Health Dis; 2017 Aug; 16(1):155. PubMed ID: 28810873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High versus low dose statin therapy in Indian patients with acute ST-segment elevation myocardial infarction undergoing thrombolysis.
    Priti K; Agrawal A; Ranwa BL
    Indian Heart J; 2017; 69(4):453-457. PubMed ID: 28822510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
    Eisen A; Cannon CP; Braunwald E; Steen DL; Zhou J; Goodrich EL; Im K; Dalby AJ; Spinar J; Daga S; Lukas MA; O'Donoghue ML
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28077384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26).
    Kerr AJ; Mitnala S; Lee M; White HD
    N Z Med J; 2020 Mar; 133(1511):21-40. PubMed ID: 32161419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome.
    Taglieri N; Marzocchi A; Saia F; Marrozzini C; Palmerini T; Ortolani P; Cinti L; Rosmini S; Vagnarelli F; Alessi L; Villani C; Scaramuzzino G; Gallelli I; Melandri G; Branzi A; Rapezzi C
    Am J Cardiol; 2011 Jul; 108(1):21-8. PubMed ID: 21529728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study.
    Simpson SH; Lin M; Eurich DT
    Ann Pharmacother; 2017 Aug; 51(8):630-639. PubMed ID: 28372491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
    Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
    Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials.
    Pan Y; Tan Y; Li B; Li X
    Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Nanchen D; Gencer B; Muller O; Auer R; Aghlmandi S; Heg D; Klingenberg R; Räber L; Carballo D; Carballo S; Matter CM; Lüscher TF; Windecker S; Mach F; Rodondi N
    Circulation; 2016 Sep; 134(10):698-709. PubMed ID: 27462068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
    Schwartz GG; Fayyad R; Szarek M; DeMicco D; Olsson AG
    Eur J Prev Cardiol; 2017 Aug; 24(12):1294-1296. PubMed ID: 28504565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality rate increases steeply with nonadherence to statin therapy in patients with acute coronary syndrome.
    Allonen J; Nieminen MS; Lokki M; Parkkonen O; Vaara S; Perola M; Hiekkalinna T; Strandberg TE; Sinisalo J
    Clin Cardiol; 2012 Nov; 35(11):E22-7. PubMed ID: 22961648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
    Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
    Shehata M; Fayez G; Nassar A
    Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL-ACS Data.
    Lewek J; Niedziela J; Desperak P; Dyrbuś K; Osadnik T; Jankowski P; Witkowski A; Bielecka-Dąbrowa A; Dudek D; Gierlotka M; Gąsior M; Banach M
    J Am Heart Assoc; 2023 Sep; 12(18):e030414. PubMed ID: 37671618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
    Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
    Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.